Navafenterol (AZD8871) in healthy volunteers: safety tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator in two phase I randomised single-blind placebo-controlled studies

摘要

Study design for (a) study A and (b) study B